Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.

Yuzefpolskaya M, Bohn B, Nasiri M, Zuver AM, Onat DD, Royzman EA, Nwokocha J, Mabasa M, Pinsino A, Brunjes D, Gaudig A, Clemons A, Trinh P, Stump S, Giddins MJ, Topkara VK, Garan AR, Takeda K, Takayama H, Naka Y, Farr MA, Nandakumar R, Uhlemann AC, Colombo PC, Demmer RT.

J Heart Lung Transplant. 2020 Feb 13. pii: S1053-2498(20)31390-5. doi: 10.1016/j.healun.2020.02.004. [Epub ahead of print]

PMID:
32139154
2.

Epidemiology of Staphylococcus aureus in neonates on admission to a Chinese neonatal intensive care unit.

Geng W, Qi Y, Li W, McConville TH, Hill-Ricciuti A, Grohs EC, Saiman L, Uhlemann AC.

PLoS One. 2020 Feb 13;15(2):e0211845. doi: 10.1371/journal.pone.0211845. eCollection 2020.

3.

Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.

Annavajhala MK, Khan SD, Sullivan SB, Shah J, Pass L, Kister K, Kunen H, Chiang V, Monnot GC, Ricupero CL, Mazur RA, Gordon P, de Jong A, Wadhwa S, Yin MT, Demmer RT, Uhlemann AC.

mSphere. 2020 Feb 5;5(1). pii: e00798-19. doi: 10.1128/mSphere.00798-19.

4.

Evaluation of the NG-Test MCR-1 Lateral Flow Assay and EDTA-Colistin Broth Disk Elution Methods To Detect Plasmid-Mediated Colistin Resistance among Gram-Negative Bacterial Isolates.

Fenwick AJ, Bergman Y, Lewis S, Yee R, Uhlemann AC, Cole N, Kohner P, Ordak C, Green DA, Schuetz AN, Humphries R, Simner PJ.

J Clin Microbiol. 2020 Mar 25;58(4). pii: e01823-19. doi: 10.1128/JCM.01823-19. Print 2020 Mar 25.

PMID:
31996440
5.

The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites.

Yoo E, Schulze CJ, Stokes BH, Onguka O, Yeo T, Mok S, Gnädig NF, Zhou Y, Kurita K, Foe IT, Terrell SM, Boucher MJ, Cieplak P, Kumpornsin K, Lee MCS, Linington RG, Long JZ, Uhlemann AC, Weerapana E, Fidock DA, Bogyo M.

Cell Chem Biol. 2020 Feb 20;27(2):143-157.e5. doi: 10.1016/j.chembiol.2020.01.001. Epub 2020 Jan 23.

PMID:
31978322
6.

Association Between Nitrate-Reducing Oral Bacteria and Cardiometabolic Outcomes: Results From ORIGINS.

Goh CE, Trinh P, Colombo PC, Genkinger JM, Mathema B, Uhlemann AC, LeDuc C, Leibel R, Rosenbaum M, Paster BJ, Desvarieux M, Papapanou PN, Jacobs DR Jr, Demmer RT.

J Am Heart Assoc. 2019 Dec 3;8(23):e013324. doi: 10.1161/JAHA.119.013324. Epub 2019 Nov 26.

7.

Evaluation of Calcium-Enhanced Media for Colistin Susceptibility Testing by Gradient Agar Diffusion and Broth Microdilution.

Green DA, Macesic N, Uhlemann AC, Lopez M, Stump S, Whittier S, Schuetz AN, Simner PJ, Humphries RM.

J Clin Microbiol. 2020 Jan 28;58(2). pii: e01522-19. doi: 10.1128/JCM.01522-19. Print 2020 Jan 28.

PMID:
31748324
8.

Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.

Annavajhala MK, Gomez-Simmonds A, Macesic N, Sullivan SB, Kress A, Khan SD, Giddins MJ, Stump S, Kim GI, Narain R, Verna EC, Uhlemann AC.

Nat Commun. 2019 Oct 17;10(1):4715. doi: 10.1038/s41467-019-12633-4.

9.

Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron.

La Carpia F, Wojczyk BS, Annavajhala MK, Rebbaa A, Culp-Hill R, D'Alessandro A, Freedberg DE, Uhlemann AC, Hod EA.

NPJ Biofilms Microbiomes. 2019 Sep 24;5:26. doi: 10.1038/s41522-019-0097-2. eCollection 2019.

10.

Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.

Macesic N, Nelson B, Mcconville TH, Giddins MJ, Green DA, Stump S, Gomez-Simmonds A, Annavajhala MK, Uhlemann AC.

Clin Infect Dis. 2019 Sep 12. pii: ciz623. doi: 10.1093/cid/ciz623. [Epub ahead of print]

PMID:
31513705
11.

Multicenter Evaluation of Colistin Broth Disk Elution and Colistin Agar Test: a Report from the Clinical and Laboratory Standards Institute.

Humphries RM, Green DA, Schuetz AN, Bergman Y, Lewis S, Yee R, Stump S, Lopez M, Macesic N, Uhlemann AC, Kohner P, Cole N, Simner PJ.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e01269-19. doi: 10.1128/JCM.01269-19. Print 2019 Nov.

PMID:
31511331
12.

Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.

Snider EJ, Compres G, Freedberg DE, Khiabanian H, Nobel YR, Stump S, Uhlemann AC, Lightdale CJ, Abrams JA.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1687-1693. doi: 10.1158/1055-9965.EPI-19-0008. Epub 2019 Aug 29.

13.

Multidrug-Resistant Klebsiella pneumoniae ST307 in Traveler Returning from Puerto Rico to Dominican Republic.

Rojas R, Macesic N, Tolari G, Guzman A, Uhlemann AC.

Emerg Infect Dis. 2019 Aug;25(8):1583-1585. doi: 10.3201/eid2508.171730.

14.

Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus.

Harrison EM, Ba X, Coll F, Blane B, Restif O, Carvell H, Köser CU, Jamrozy D, Reuter S, Lovering A, Gleadall N, Bellis KL, Uhlemann AC, Lowy FD, Massey RC, Grilo IR, Sobral R, Larsen J, Rhod Larsen A, Vingsbo Lundberg C, Parkhill J, Paterson GK, Holden MTG, Peacock SJ, Holmes MA.

Nat Microbiol. 2019 Oct;4(10):1680-1691. doi: 10.1038/s41564-019-0471-0. Epub 2019 Jun 24.

PMID:
31235959
15.

Reduced mortality of Staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007 - 2015.

Austin ED, Sullivan SS, Macesic N, Mehta M, Miko BA, Nematollahi S, Shi Q, Lowy FD, Uhlemann AC.

Clin Infect Dis. 2019 Jun 11. pii: ciz498. doi: 10.1093/cid/ciz498. [Epub ahead of print]

PMID:
31185081
16.

Escherichia coli Harboring mcr-1 in a Cluster of Liver Transplant Recipients: Detection through Active Surveillance and Whole-Genome Sequencing.

Macesic N, Khan S, Giddins MJ, Freedberg DE, Whittier S, Green DA, Furuya EY, Verna EC, Annavajhala MK, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02680-18. doi: 10.1128/AAC.02680-18. Print 2019 Jun.

17.

Systematic Review of Gut Microbiota and Major Depression.

Cheung SG, Goldenthal AR, Uhlemann AC, Mann JJ, Miller JM, Sublette ME.

Front Psychiatry. 2019 Feb 11;10:34. doi: 10.3389/fpsyt.2019.00034. eCollection 2019.

18.

Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound.

Garcia PK, Annamalai T, Wang W, Bell RS, Le D, Martin Pancorbo P, Sikandar S, Seddek A, Yu X, Sun D, Uhlemann AC, Tiwari PB, Leng F, Tse-Dinh YC.

PLoS One. 2019 Feb 22;14(2):e0207733. doi: 10.1371/journal.pone.0207733. eCollection 2019.

19.

Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat.

Annavajhala MK, Gomez-Simmonds A, Uhlemann AC.

Front Microbiol. 2019 Jan 31;10:44. doi: 10.3389/fmicb.2019.00044. eCollection 2019.

20.

Metabolic Adaptation in Methicillin-Resistant Staphylococcus aureus Pneumonia.

Gabryszewski SJ, Wong Fok Lung T, Annavajhala MK, Tomlinson KL, Riquelme SA, Khan IN, Noguera LP, Wickersham M, Zhao A, Mulenos AM, Peaper D, Koff JL, Uhlemann AC, Prince A.

Am J Respir Cell Mol Biol. 2019 Aug;61(2):185-197. doi: 10.1165/rcmb.2018-0389OC.

21.

Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus.

Copin R, Sause WE, Fulmer Y, Balasubramanian D, Dyzenhaus S, Ahmed JM, Kumar K, Lees J, Stachel A, Fisher JC, Drlica K, Phillips M, Weiser JN, Planet PJ, Uhlemann AC, Altman DR, Sebra R, van Bakel H, Lighter J, Torres VJ, Shopsin B.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1745-1754. doi: 10.1073/pnas.1814265116. Epub 2019 Jan 11. Erratum in: Proc Natl Acad Sci U S A. 2019 Feb 25;:.

22.

BacCapSeq: a Platform for Diagnosis and Characterization of Bacterial Infections.

Allicock OM, Guo C, Uhlemann AC, Whittier S, Chauhan LV, Garcia J, Price A, Morse SS, Mishra N, Briese T, Lipkin WI.

mBio. 2018 Oct 23;9(5). pii: e02007-18. doi: 10.1128/mBio.02007-18.

23.

Beware of broad-spectrum generalizations: ceftazidime-avibactam compared to meropenem for the treatment of gram-negative pneumonia.

Mehta M, Uhlemann AC.

J Emerg Crit Care Med. 2018 May;2. pii: 45. doi: 10.21037/jeccm.2018.05.02. Epub 2018 May 15. No abstract available.

24.

Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection.

Freedberg DE, Zhou MJ, Cohen ME, Annavajhala MK, Khan S, Moscoso DI, Brooks C, Whittier S, Chong DH, Uhlemann AC, Abrams JA.

Intensive Care Med. 2018 Aug;44(8):1203-1211. doi: 10.1007/s00134-018-5268-8. Epub 2018 Jun 23.

25.

Clonal Background, Resistance Gene Profile, and Porin Gene Mutations Modulate In Vitro Susceptibility to Imipenem-Relebactam in Diverse Enterobacteriaceae.

Gomez-Simmonds A, Stump S, Giddins MJ, Annavajhala MK, Uhlemann AC.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00573-18. doi: 10.1128/AAC.00573-18. Print 2018 Aug.

26.

Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant Enterobacter cloacae Complex Clones ST171 and ST78.

Gomez-Simmonds A, Annavajhala MK, Wang Z, Macesic N, Hu Y, Giddins MJ, O'Malley A, Toussaint NC, Whittier S, Torres VJ, Uhlemann AC.

mBio. 2018 May 29;9(3). pii: e00542-18. doi: 10.1128/mBio.00542-18.

27.

Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.

Macesic N, Gomez-Simmonds A, Sullivan SB, Giddins MJ, Ferguson SA, Korakavi G, Leeds D, Park S, Shim K, Sowash MG, Hofbauer M, Finkel R, Hu Y, West J, Toussaint NC, Greendyke WG, Miko BA, Pereira MR, Whittier S, Verna EC, Uhlemann AC.

Clin Infect Dis. 2018 Aug 31;67(6):905-912. doi: 10.1093/cid/ciy199.

28.

New York City House Mice (Mus musculus) as Potential Reservoirs for Pathogenic Bacteria and Antimicrobial Resistance Determinants.

Williams SH, Che X, Paulick A, Guo C, Lee B, Muller D, Uhlemann AC, Lowy FD, Corrigan RM, Lipkin WI.

mBio. 2018 Apr 17;9(2). pii: e00624-18. doi: 10.1128/mBio.00624-18.

29.

Demographic fluctuation of community-acquired antibiotic-resistant Staphylococcus aureus lineages: potential role of flimsy antibiotic exposure.

Gustave CA, Tristan A, Martins-Simões P, Stegger M, Benito Y, Andersen PS, Bes M, Le Hir T, Diep BA, Uhlemann AC, Glaser P, Laurent F, Wirth T, Vandenesch F.

ISME J. 2018 Aug;12(8):1879-1894. doi: 10.1038/s41396-018-0110-4. Epub 2018 Mar 29.

30.

Barrett's esophagus is associated with a distinct oral microbiome.

Snider EJ, Compres G, Freedberg DE, Giddins MJ, Khiabanian H, Lightdale CJ, Nobel YR, Toussaint NC, Uhlemann AC, Abrams JA.

Clin Transl Gastroenterol. 2018 Feb 20;9(3):135. doi: 10.1038/s41424-018-0005-8.

31.

Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates.

Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02101-17. doi: 10.1128/AAC.02101-17. Print 2018 Mar.

32.

Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.

McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann AC.

PLoS One. 2017 Oct 12;12(10):e0186195. doi: 10.1371/journal.pone.0186195. eCollection 2017.

33.

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?

Macesic N, Nelson B, Uhlemann AC.

Clin Infect Dis. 2017 Aug 15;65(4):702-703. doi: 10.1093/cid/cix393. No abstract available.

34.

Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"

Cheng L, Nelson BC, Mehta M, Shi Q, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01163-17. doi: 10.1128/AAC.01163-17. Print 2017 Sep. No abstract available.

35.

Detection of mcr-1-Carrying Escherichia coli Causing Bloodstream Infection in a New York City Hospital: Avian Origins, Human Concerns?

Macesic N, Green D, Wang Z, Sullivan SB, Shim K, Park S, Whittier S, Furuya EY, Gomez-Simmonds A, Uhlemann AC.

Open Forum Infect Dis. 2017 May 20;4(3):ofx115. doi: 10.1093/ofid/ofx115. eCollection 2017 Summer.

36.

Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection.

Sullivan SB, Austin ED, Stump S, Mathema B, Whittier S, Lowy FD, Uhlemann AC.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00316-17. doi: 10.1128/AAC.00316-17. Print 2017 Jul.

37.

The Surface Protein SdrF Mediates Staphylococcus epidermidis Adherence to Keratin.

Trivedi S, Uhlemann AC, Herman-Bausier P, Sullivan SB, Sowash MG, Flores EY, Khan SD, Dufrêne YF, Lowy FD.

J Infect Dis. 2017 Jun 15;215(12):1846-1854. doi: 10.1093/infdis/jix213.

38.

Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Gomez-Simmonds A, Uhlemann AC.

J Infect Dis. 2017 Feb 15;215(suppl_1):S18-S27. doi: 10.1093/infdis/jiw378. Review.

39.

Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.

Cheng L, Nelson BC, Mehta M, Seval N, Park S, Giddins MJ, Shi Q, Whittier S, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00276-17. doi: 10.1128/AAC.00276-17. Print 2017 Jun.

40.

Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.

Jung B, Mahul M, Breilh D, Legeron R, Signe J, Jean-Pierre H, Uhlemann AC, Molinari N, Jaber S.

Crit Care Med. 2017 May;45(5):e470-e478. doi: 10.1097/CCM.0000000000002287.

PMID:
28240688
41.

Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.

Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, Juretschko S, Rojtman AD, Hong T, Mathema B, Jacobs MR, Walsh TJ, Bonomo RA, Kreiswirth BN.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02349-16. doi: 10.1128/AAC.02349-16. Print 2017 Apr.

42.

Evolutionary Dynamics of Pandemic Methicillin-Sensitive Staphylococcus aureus ST398 and Its International Spread via Routes of Human Migration.

Uhlemann AC, McAdam PR, Sullivan SB, Knox JR, Khiabanian H, Rabadan R, Davies PR, Fitzgerald JR, Lowy FD.

mBio. 2017 Jan 17;8(1). pii: e01375-16. doi: 10.1128/mBio.01375-16.

43.

Staphylococcus epidermidis Protection Against Staphylococcus aureus Colonization in People Living With Human Immunodeficiency Virus in an Inner-City Outpatient Population: A Cross-Sectional Study.

Sullivan SB, Kamath S, McConville TH, Gray BT, Lowy FD, Gordon PG, Uhlemann AC.

Open Forum Infect Dis. 2016 Dec 20;3(4):ofw234. doi: 10.1093/ofid/ofw234. eCollection 2016 Oct.

44.

Acquired resistance to innate immune clearance promotes Klebsiella pneumoniae ST258 pulmonary infection.

Ahn D, Peñaloza H, Wang Z, Wickersham M, Parker D, Patel P, Koller A, Chen EI, Bueno SM, Uhlemann AC, Prince A.

JCI Insight. 2016 Oct 20;1(17):e89704. doi: 10.1172/jci.insight.89704.

45.

A Novel MSCRAMM Subfamily in Coagulase Negative Staphylococcal Species.

Arora S, Uhlemann AC, Lowy FD, Hook M.

Front Microbiol. 2016 Apr 29;7:540. doi: 10.3389/fmicb.2016.00540. eCollection 2016.

46.

Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection.

Austin ED, Sullivan SB, Whittier S, Lowy FD, Uhlemann AC.

Open Forum Infect Dis. 2016 Apr 6;3(2):ofw072. doi: 10.1093/ofid/ofw072. eCollection 2016 Mar.

47.

Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.

Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnädig N, Uhlemann AC, Martin RE, Lehane AM, Fidock DA.

Nat Commun. 2016 May 18;7:11553. doi: 10.1038/ncomms11553.

48.

Association of Environmental Contamination in the Home With the Risk for Recurrent Community-Associated, Methicillin-Resistant Staphylococcus aureus Infection.

Knox J, Sullivan SB, Urena J, Miller M, Vavagiakis P, Shi Q, Uhlemann AC, Lowy FD.

JAMA Intern Med. 2016 Jun 1;176(6):807-15. doi: 10.1001/jamainternmed.2016.1500.

49.

Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14.

Gomez-Simmonds A, Hu Y, Sullivan SB, Wang Z, Whittier S, Uhlemann AC.

J Antimicrob Chemother. 2016 Aug;71(8):2351-3. doi: 10.1093/jac/dkw132. Epub 2016 Apr 26. Review. No abstract available.

50.

The evolving threat of carbapenem-resistant infections after liver transplantation: The case of Acinetobacter baumannii.

Pereira MR, Uhlemann AC.

Liver Transpl. 2016 May;22(5):579-81. doi: 10.1002/lt.24428. No abstract available.

Supplemental Content

Loading ...
Support Center